FundCalibre’s McDermott: Anti-obesity drugs will drive healthcare in 2024
Demand for GLP-1 medications is skyrocketing
Demand for GLP-1 medications is skyrocketing
|
|
Seven strategies received the rating while four were awarded the ‘Elite Radar’ badge
|
|
COP28 will set the themes that drive greater innovation in investing
|
|
Darius McDermott and Martin Walker discuss whether investors are right to be spurning their domestic market as they leave the UK All Companies sector in droves
|
|
Is the narrow performance of US tech giants desirable or sustainable?
|
|
FP Carmignac Emerging Markets fund awarded Elite rating
|
|
FundCalibre has retained the £1bn Artemis Strategic Bond fund’s rating despite management overhaul
|
|
Analysts from German asset manager DWS made a bold prediction
|
|
He will become a senior advisor to the firm when he steps back from day-to-day work
|
|
Orbis Global Balanced also among the seven new ratings
|
|
One area of the market is still being overlooked
|
|
He has been the lead manager of the trust for close to 20 years
|
|